Kyntra Bio, Inc. (BMV:KYNB)

Kyntra Bio Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	609	1,112	1,473	29,361	26,798	67,169
Market Cap Growth	-44.69%	-24.54%	-94.98%	9.56%	-60.10%	-4.84%
Enterprise Value	-517	1,194	817	23,888	19,687	55,081
Last Close Price	162.00	298.75	377.00	7025.00	7225.00	19250.00
PS Ratio	4.00	1.80	1.86	10.70	5.56	19.15
PB Ratio	1.90	-0.29	-0.54	-1017.03	5.71	7.65
P/TBV Ratio	-	-	-	-	6.25	8.00
P/FCF Ratio	-	-	-	-	-	43.50
P/OCF Ratio	-	-	-	-	-	41.37
EV/Sales Ratio	-	1.93	1.03	8.70	4.08	15.70
EV/FCF Ratio	1.65	-	-	-	-	35.67
Debt / Equity Ratio	1.11	-0.49	-1.03	-72.28	0.51	0.13
Debt / FCF Ratio	-	-	-	-	-	0.75
Asset Turnover	0.04	0.09	0.09	0.20	0.29	0.21
Inventory Turnover	2.78	10.95	10.24	8.40	18.90	22.26
Quick Ratio	3.56	0.60	1.09	1.60	1.91	4.46
Current Ratio	3.71	1.47	1.52	1.80	2.10	4.63
Return on Equity (ROE)	-	-	-	-258.01%	-86.50%	-38.76%
Return on Assets (ROA)	-18.42%	-25.66%	-40.48%	-27.19%	-27.22%	-14.24%
Return on Capital Employed (ROCE)	-58.50%	-161.20%	-162.60%	-89.50%	-63.60%	-28.90%
Earnings Yield	650.03%	-89.17%	-326.11%	-19.51%	-22.19%	-5.61%
FCF Yield	-51.52%	-259.13%	-364.32%	-9.94%	-6.69%	2.30%
Buyback Yield / Dilution	-1.55%	-2.82%	-3.98%	-1.33%	-2.78%	-3.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.